Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azeloprazole vs Rabeprazole in Erosive Esophagitis
NCT02463643Phase 2Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- May 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azeloprazole in erosive esophagitis (EE), sponsored by Zeria Pharmaceutical Co., Ltd.. Started May 2015; status: completed.
02
Drugs
azeloprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT02463643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02463643.